Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02861131 · ClinicalTrials.gov registry record · Phase 4
The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
A Phase 4 study of Postoperative Complications and Neuromuscular Blockade, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT02861131 is a Phase 4 study of Postoperative Complications and Neuromuscular Blockade that has completed, run by Oregon Health and Science University. The registered enrollment target is 200 participants, below the 375-participant average among 17 other Postoperative Complications trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02861131, a Phase 4 study of Postoperative Complications and Neuromuscular Blockade, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Substantial respiratory morbidity has been associated with postoperative residual paralysis, which is fairly common after general anesthesia involving a neuromuscular blocking agent. Common practice in United States is to reverse neuromuscular blockade with neostigmine at the end of surgery. A new drug with evidence of more complete neuromuscular reversal has been developed, sugammadex. The objective of this study is to determine if a strategy of rocuronium neuromuscular reversal with sugammadex will reduce the proportion of subjects with any postoperative pulmonary complication, compared to neostigmine.
Conditions Studied
Interventions
- DRUG Sugammadex
- DRUG Neostigmine
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-01-24 |
| Est. Completion | 2018-04-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02861131
The ClinicalTrials.gov registry entry for NCT02861131 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 375-participant average among 17 other Postoperative Complications trials with a reported enrollment target (47% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Postoperative Complications appearing as the primary indexed condition, and to 2 interventions - of which Sugammadex is the first listed.
NCT02861131 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT02861131 about?
NCT02861131 is a clinical study titled "The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications". Substantial respiratory morbidity has been associated with postoperative residual paralysis, which is fairly common after general anesthesia involving a neuromuscular blocking agent. Common practice in United States is to reverse neuromuscular blockade with neostigmine at the end of surgery. A new d...
What is the current status of trial NCT02861131?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2017-01-24. Estimated completion is 2018-04-30.
What conditions does trial NCT02861131 study?
This clinical trial studies the following conditions: Postoperative Complications, Neuromuscular Blockade.
What interventions are being tested in trial NCT02861131?
The interventions under investigation include: Sugammadex (DRUG), Neostigmine (DRUG).
Who is sponsoring clinical trial NCT02861131?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02861131 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition to Support Postoperative Recovery
RECRUITING · NA
-
Minimally Invasive Esophagectomy Pain Control Trial
RECRUITING · Phase 1
-
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
RECRUITING · Phase 2
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures
RECRUITING
-
Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.